Comparison of the pharmacovigilance signals of cardiac and renal adverse events associated with sacubitril/valsartan and valsartan alone based on the FAERS database
Sacubitril/valsartan carries a higher renal safety risk and lower cardiac safety risk than valsartan alone.
Authors
- Gang Peng (ORCID: https://orcid.org/0000-0001-6625-5426)
- Dapeng Yan (ORCID: https://orcid.org/0000-0002-1977-8977)
- Yan Zhou (ORCID: https://orcid.org/0000-0001-6685-2634)
- Yun Shen (ORCID: https://orcid.org/0000-0002-8225-1940)
- Yanrong Ye (ORCID: https://orcid.org/0000-0002-8189-1292)
- Yao Xu (ORCID: https://orcid.org/0000-0003-4601-665X)
- Zhenhui Chen (ORCID: https://orcid.org/0000-0001-8707-9521)
- Qining Qiu
- Jingwen Li (ORCID: https://orcid.org/0009-0000-3382-6341)
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1080/14740338.2024.2436100
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00